Coverart for item
The Resource Overdose : how excessive government regulation stifles pharmaceutical innovation, Richard A. Epstein

Overdose : how excessive government regulation stifles pharmaceutical innovation, Richard A. Epstein

Label
Overdose : how excessive government regulation stifles pharmaceutical innovation
Title
Overdose
Title remainder
how excessive government regulation stifles pharmaceutical innovation
Statement of responsibility
Richard A. Epstein
Creator
Contributor
Subject
Language
eng
Summary
This book is the first to offer a comprehensive examination of the pharmaceutical industry by following the tortuous course of a new drug as it progresses from early development to final delivery. Richard A. Epstein looks closely at the regulatory framework that surrounds all aspects of making pharmaceutical products today, and he assesses which current legal and regulatory practices make sense and which have gone awry. While critics of pharmaceutical companies call for ever more stringent controls on virtually every aspect of drug development and approval, Epstein cautions that the effect of such an approach will be to stifle pharmaceutical innovation and slow the delivery of beneficial treatments to the patients who need them. The author considers an array of challenges that confront the industry--conflicts of interest among government, academe, and the drug companies; intellectual property rights that govern patents; FDA regulation; pricing disputes; marketing practices; and liability issues, including those brought to light in the recent VIOXX case. Epstein argues that to ensure the continuing creativity, efficiency, and success of the pharmaceutical industry, the best system will feature strong property rights and clearly enforceable contracts, with minimal regulatory and judicial interference
Cataloging source
DNLM/DLC
http://library.link/vocab/creatorDate
1943-
http://library.link/vocab/creatorName
Epstein, Richard Allen
Dewey number
338.4/761510973
Index
index present
LC call number
HD9666.6
LC item number
.E68 2006
Literary form
non fiction
Nature of contents
bibliography
NLM call number
QV 736
NLM item number
E64o 2006
http://library.link/vocab/relatedWorkOrContributorName
Yale University
http://library.link/vocab/subjectName
  • United States
  • Pharmaceutical industry
  • Drug Industry
  • Government Regulation
  • Public Policy
  • United States
  • United States
Label
Overdose : how excessive government regulation stifles pharmaceutical innovation, Richard A. Epstein
Instantiates
Publication
Note
"An Institute for Policy Innovation Book."
Bibliography note
Includes bibliographical references (pages 241-271) and index
Carrier category
volume
Carrier category code
nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
Rising expectations-- and diminishing returns -- Property generally : externalities, coordination, and the public domain -- Intellectual property: the public domain and private rights -- Taming conflict of interests -- Federally sponsored research under Bayh-Dole -- The anticommons -- The single monopoly : current patent limitations -- Rate regulation : an unneeded swamp -- Patent purchases: a second swamp -- Socialization of R & D : the final swamp -- The steady expansion of FDA power -- FDA versus the individual : upstream or downstream decision making -- Drug withdrawal : too much, too soon -- Getting the drugs to market -- Deceptive marketing -- Tort preliminaries -- Product liability for prescription drugs : manufacturing and design cases -- The main event : misrepresentation, overpromotion, and duty to warn -- Conclusion : socialized medicines
Control code
64688339
Dimensions
25 cm
Extent
xi, 283 pages
Isbn
9780300116649
Isbn Type
(cloth : alk. paper)
Lccn
2006006514
Media category
unmediated
Media MARC source
rdamedia
Media type code
n
Other control number
9780300116649
Label
Overdose : how excessive government regulation stifles pharmaceutical innovation, Richard A. Epstein
Publication
Note
"An Institute for Policy Innovation Book."
Bibliography note
Includes bibliographical references (pages 241-271) and index
Carrier category
volume
Carrier category code
nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
Rising expectations-- and diminishing returns -- Property generally : externalities, coordination, and the public domain -- Intellectual property: the public domain and private rights -- Taming conflict of interests -- Federally sponsored research under Bayh-Dole -- The anticommons -- The single monopoly : current patent limitations -- Rate regulation : an unneeded swamp -- Patent purchases: a second swamp -- Socialization of R & D : the final swamp -- The steady expansion of FDA power -- FDA versus the individual : upstream or downstream decision making -- Drug withdrawal : too much, too soon -- Getting the drugs to market -- Deceptive marketing -- Tort preliminaries -- Product liability for prescription drugs : manufacturing and design cases -- The main event : misrepresentation, overpromotion, and duty to warn -- Conclusion : socialized medicines
Control code
64688339
Dimensions
25 cm
Extent
xi, 283 pages
Isbn
9780300116649
Isbn Type
(cloth : alk. paper)
Lccn
2006006514
Media category
unmediated
Media MARC source
rdamedia
Media type code
n
Other control number
9780300116649

Library Locations

    • Ellis LibraryBorrow it
      1020 Lowry Street, Columbia, MO, 65201, US
      38.944491 -92.326012
Processing Feedback ...